Loading...
Depo testosterone dosage is typically determined based on condition under treatment.
As one of the most common forms of testosterone used in the treatment of hypogonadism or low testosterone (low T) in men.
It’s also one of the most misused and abused by bodybuilders and athletes.
Depo testosterone side effects also occur when dosages are higher than recommended.
Have you been prescribed Depo by your physician or you’re thinking of using it for your bodybuilding or athletic enhancement endeavors?
Take the time to know what it does in the body, dosage recommendations, side effects, and interactions. Buy Testo-Max online here.
Table of Contents
Depo Testosterone Dosage Bodybuilding
Use of Depo and Depo testosterone dosage suggestions are often catered to individual goals.
Individual reactions can vary by:
- Milligram strength
- Dosage
- Frequency of dosage
- Age
- Weight versus eight/body composition
- Metabolism
The higher the dosage, the increased risk of Depo testosterone side effects. The drug is available in 1 mL or 10 mL vials in a typical potency of 200 mg per milliliter.
Testosterone cypionate has a half-life that can average up to 25 days, peaking at about eight days following the injection. Of course, the dose can also influence activity of the drug.
In a medical scenario, side effect potential was reduced by the physician suggesting the Depo testosterone dosage chart start at about 50 mg every two weeks to a month and up to 400 mg if needed.
Bodybuilders are commonly known to inject Depo testosterone on a weekly schedule with the testosterone dosage ranging from 200 mg weekly to 600 mg weekly. A shorter cycle averages roughly 6 weeks, while a longer cycle averages 12.
The higher the dosages and frequency of dosage, the increased risk of Depo testosterone side effects.
Mild To Serious Depo Testosterone Side Effects
Testosterone cypionate is highly susceptible to aromatization, meaning conversion of testosterone to estrogen.
To reduce the potential for estrogen type Depo testosterone injections side effects, bodybuilders often turn to aromatase inhibitors and anti-estrogen drugs.
These drugs help reduce the risk of female type side effects such as the dreaded gynecomastia, water retention, and abdominal bloating.
Anabolic androgenic drugs such as testosterone cypionate can also increase the risk of serious and often life-threatening side effects and adverse reactions that can impact the health of vital organs and systems in the body.
Androgen levels are also raised due to the introduction of exogenous Testosterone Cypionate, and androgen-related side effects can occur.
Testosterone converts to Dihydrotestosterone (DHT) by way of the 5-alpha reductase/5AR enzyme found in different tissues in the human body, such as the skin, prostate and scalp.
DHT is at least 3 times more powerful than Testosterone, and the most severe androgenic effects manifest due to the conversion to DHT.
Some auxiliary drugs such as Dutasteride and Proscar have been cycled by bodybuilders in an attempt to inhibit the 5-alpha reductase enzyme and help eliminate DHT at it root.
However this is not considered to stop the side effects on various parts of the body.
Some performance users of Testosterone C have also opted to cycle Nizoral 2%, which is taken to help with androgen-induced male pattern baldness.
It contains Ketoconazole which is known to act as an androgen inhibitor as it is topically applied on the scalp and area where androgen-triggered acne may occur.
Some androgenic related side effects may include:
- Increased acne
- Increase sebum secretion
- Facial and bodily hair growth
- Elevated risk of Male Pattern Baldness (MPB) for people who have the genetic marking needed for the condition to manifest
About Depo Testosterone
Depo testosterone is popular in bodybuilding circles, more commonly known as testosterone cypionate.
It’s a synthetic variation of the male hormone testosterone.
As such, it behaves just like testosterone in regard to anabolic or tissue building, and in its androgenic or male characteristic promoting characteristics.
Numerous forms of testosterone are available today, both through prescription and procurement from underground labs and black market resources. Depo testosterone is known by numerous chemical names that include:
- Depo
- Depo testosterone
- Depovirin
- Pertestis
- DepAndro100
- Depo Testosterone 100 mg
While easier to identify by its molecular formula (C27H40O3), users will find it under different names and nicknames depending on the manufacturer (legal and licensed pharmaceutical company or underground lab) and country of origin.
As with any drug, prescription or otherwise, Depo testosterone side effects are not always dosage dependent. Any testosterone Cypionate injection dosage is considered illegal without a prescription.
Depo is a Schedule III controlled substance that is only legal to use with a doctor’s supervision and within legitimate prescription guidelines.
In medical scenarios, testosterone cypionate dosage for low T and other usage factors may be indicated for the treatment of:
- Primary hypogonadism
- Hypergonadotropic hypogonadism (acquired or congenital)
It’s no secret that bodybuilders and athletes have long misused various forms of synthetic forms of testosterone for its anabolic androgenic properties.
Mechanism of Action
The primary mechanism of action of testosterone cypionate is to promote male sex characteristic maintenance. It is a common form of testosterone replacement therapy.
Dosage may also be influenced by the manufacturer and quality of product, as well as milligram strength of the product.
Bottom line: Depo testosterone side effects are possible regardless of Depo testosterone injections dosage bodybuilding users take.
Taking drugs to reduce potential side effects are not a guarantee that major body organs will not be affected by the anabolic androgenic steroid.
Depo TestosteroneDepo Testosterone CypionateDepo Testosterone DosageDepo Testosterone for SaleDepo Testosterone ReviewsTestosterone CypionateTestosterone Cypionate CycleTestosterone Cypionate DosageTestosterone Cypionate InjectionTestosterone Cypionate PriceTestosterone Cypionate Propionate EnanthateReferences
- Gannon JR et al . Testosterone and Sexual Function. Urol Clin North Am. 2016 May;43(2):217-22. doi: 10.1016/j.ucl.2016.01.008. Epub 2016 Mar 21. Review.
- Zimmerman Y et al . The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis. Hum Reprod Update. 2014 Jan-Feb;20(1):76-105. doi: 10.1093/humupd/dmt038. Epub 2013 Sep 29. Review.
- Crespi BJ. Oxytocin, testosterone, and human social cognition. Biol Rev Camb Philos Soc. 2016 May;91(2):390-408. doi: 10.1111/brv.12175. Epub 2015 Jan 28. Review.
- Morgentaler A et al . Commentary: Who is a candidate for testosterone therapy? A synthesis of international expert opinions. J Sex Med. 2014 Jul;11(7):1636-45. doi: 10.1111/jsm.12546. Epub 2014 May 2.
- West DW et al . Anabolic processes in human skeletal muscle: restoring the identities of growth hormone and testosterone. Phys Sportsmed. 2010 Oct;38(3):97-104. doi: 10.3810/psm.2010.10.1814. Review.
- Miner MM et al . Testosterone and ageing: what have we learned since the Institute of Medicine report and what lies ahead? Int J Clin Pract. 2007 Apr;61(4):622-32. Epub 2007 Mar 2. Review.
- Kirby EW et al . Low testosterone has a similar prevalence among men with sexual dysfunction due to either Peyronie’s disease or erectile dysfunction and does not correlate with Peyronie’s disease severity. J Sex Med. 2015 Mar;12(3):690-6. doi: 10.1111/jsm.12805. Epub 2015 Jan 8.
- Kraemer RR et al . Endocrine alterations from concentric vs. eccentric muscle actions: a brief review. Metabolism. 2015 Feb;64(2):190-201. doi: 10.1016/j.metabol.2014.10.024. Epub 2014 Oct 31. Review.
- Fernández-Miró M et al . [Testosterone deficiency, metabolic syndrome and diabetes mellitus]. Med Clin (Barc). 2016 Jan 15;146(2):69-73. doi: 10.1016/j.medcli.2015.06.020. Epub 2015 Oct 1. Review. Spanish.
- Arver S et al . Current guidelines for the diagnosis of testosterone deficiency. Front Horm Res. 2009;37:5-20. doi: 10.1159/000175839. Review.
